Document is current
Any future updates will be listed below
-
Authors
Desai, Nihar R.
Lopalco, Pier L.
- License Information
-
More Information
Article History
Received: 20 May 2024
Accepted: 3 October 2024
First Online: 18 November 2024
Declarations
:
: Dr Nihar Desai declares receipt of consulting fees within the past 36 months (of podcast article submission) from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Cytokinetics, Merck, Novartis, CSL Behring, CSL Vifor, SC Pharmaceuticals and Verve Therapeutics. Prof Pier Luigi Lopalco declares receipt of consulting fees, payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events, support for attending meetings and/or travel within the past 36 months (of podcast article submission) from, GSK, Moderna, MSD, Novavax, Pfizer, Sanofi and CLS Seqirus.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
